"For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

Seattle, Washington

0 studies enrolling now · 1 studies all time

What they study most

Colorectal Cancer

Studies at this site

• A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer. — Completed